DE60020381D1 - Substituierte benzylthiazolidin-2,4-dion-derivate - Google Patents

Substituierte benzylthiazolidin-2,4-dion-derivate

Info

Publication number
DE60020381D1
DE60020381D1 DE60020381T DE60020381T DE60020381D1 DE 60020381 D1 DE60020381 D1 DE 60020381D1 DE 60020381 T DE60020381 T DE 60020381T DE 60020381 T DE60020381 T DE 60020381T DE 60020381 D1 DE60020381 D1 DE 60020381D1
Authority
DE
Germany
Prior art keywords
group
unsubstituted
substituted benzylthiazolidine
substituents
denotes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60020381T
Other languages
English (en)
Other versions
DE60020381T2 (de
Inventor
Hiroyuki Miyachi
Masahiro Nomura
Takahiro Tanase
Koji Murakami
Masaki Tsunoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60020381D1 publication Critical patent/DE60020381D1/de
Publication of DE60020381T2 publication Critical patent/DE60020381T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE60020381T 1999-08-23 2000-08-18 Substituierte benzylthiazolidin-2,4-dion-derivate Expired - Fee Related DE60020381T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP23552799 1999-08-23
JP23552799 1999-08-23
JP2000242706 2000-08-10
JP2000242706 2000-08-10
PCT/JP2000/005519 WO2001014349A1 (fr) 1999-08-23 2000-08-18 Derives de benzylthiazolidine-2,4-dione substitues

Publications (2)

Publication Number Publication Date
DE60020381D1 true DE60020381D1 (de) 2005-06-30
DE60020381T2 DE60020381T2 (de) 2006-01-26

Family

ID=26532180

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60020381T Expired - Fee Related DE60020381T2 (de) 1999-08-23 2000-08-18 Substituierte benzylthiazolidin-2,4-dion-derivate

Country Status (10)

Country Link
US (1) US6730687B1 (de)
EP (1) EP1213287B1 (de)
KR (1) KR100738245B1 (de)
CN (1) CN1155586C (de)
AT (1) ATE296294T1 (de)
AU (1) AU778720B2 (de)
CA (1) CA2382574A1 (de)
DE (1) DE60020381T2 (de)
HU (1) HUP0202520A3 (de)
WO (1) WO2001014349A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
TWI262185B (en) * 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
AU2002222574A1 (en) * 2000-12-05 2002-06-18 Kyorin Pharmaceutical Co. Ltd. Substituted carboxylic acid derivatives
EP1911462A3 (de) 2001-01-26 2011-11-30 Schering Corporation Zusammensetzungen enthaltend einen Sterolabsorptionshemmer
FR2836683B1 (fr) * 2002-03-01 2006-06-23 Galderma Res & Dev NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
FR2833949B1 (fr) * 2001-12-21 2005-08-05 Galderma Res & Dev NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
US6908939B2 (en) 2001-12-21 2005-06-21 Galderma Research & Development S.N.C. Biaromatic ligand activators of PPARγ receptors
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
US7781464B2 (en) 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
WO2005058813A2 (en) * 2003-12-17 2005-06-30 Ranbaxy Laboratories Limited Thiodiazolidinedione, oxazolidinedione and diazolidinedione derivatives and their use as antidiabetic agents
TW200827343A (en) * 2006-09-11 2008-07-01 Fuji Yakuhin Co Ltd Novel phenylacetic acid derivative
UY31952A (es) * 2008-07-02 2010-01-29 Astrazeneca Ab 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
CN116217511B (zh) * 2023-03-22 2024-04-19 沈阳药科大学 一种双靶点化合物及其制备方法和在制备sEH抑制剂与PPARs激动剂中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223522A (en) * 1988-03-08 1993-06-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
JP3929512B2 (ja) * 1995-06-02 2007-06-13 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3906935B2 (ja) 1995-12-18 2007-04-18 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
AU2231397A (en) * 1996-03-08 1997-09-22 Torii Pharmaceutical Co., Ltd. Thiazolidine-2,4-dione derivatives
IL120443A (en) 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
JPH09301963A (ja) * 1996-05-17 1997-11-25 Kyorin Pharmaceut Co Ltd Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3982645B2 (ja) * 1996-09-06 2007-09-26 杏林製薬株式会社 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体の製造中間体
GB0127805D0 (en) 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition

Also Published As

Publication number Publication date
AU778720B2 (en) 2004-12-16
HUP0202520A2 (hu) 2002-11-28
EP1213287B1 (de) 2005-05-25
US6730687B1 (en) 2004-05-04
CN1155586C (zh) 2004-06-30
KR100738245B1 (ko) 2007-07-12
EP1213287A4 (de) 2002-09-18
CN1382129A (zh) 2002-11-27
DE60020381T2 (de) 2006-01-26
CA2382574A1 (en) 2001-03-01
KR20020040774A (ko) 2002-05-30
ATE296294T1 (de) 2005-06-15
HUP0202520A3 (en) 2004-11-29
AU6594500A (en) 2001-03-19
EP1213287A1 (de) 2002-06-12
WO2001014349A1 (fr) 2001-03-01

Similar Documents

Publication Publication Date Title
CY1108586T1 (el) Υποκαταστημενα παραγωγα φαινυλοπροπιονικου οξεος
DE60020381D1 (de) Substituierte benzylthiazolidin-2,4-dion-derivate
MEP11508A (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
ATE330930T1 (de) Neue ethylaminderivate
NO20062936L (no) Fremgangsmate for fremstilling av N-alkyl-2(hydroksy-4-benzoyl)-3-benzofuraner og dets mellomprodukter derav
DK0754682T3 (da) Aminostilbazolderivat og lægemiddel
ES2192584T3 (es) Derivado pirimidinilpirazol.
ID24846A (id) Turunan-turunan bifenilamidina
DE69931051D1 (de) Neue vinylbenzolderivate
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
DE60020573D1 (de) Substituierte benzylthiazolidin-2,4-dion derivate
ATE295841T1 (de) Substituierte benzylthiazolidin-2,4-dion derivate
FR2629455B1 (fr) Derives de 2-(3-pyridinyl)3-(phenoxy) propanenitrile
ATE296293T1 (de) Substituierte benzylthiazolidin-2,4-dion derivate
DE60307792D1 (de) Hydroxylierte indirubinderivate
HUP0301561A2 (hu) Triazintrion-szulfoxidok alkalmazása kokcidiózis elleni készítmények elżállítására
DE69108195D1 (de) Astaxanthin-Zwischenprodukte.
MY128711A (en) Use of thiazole derivatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease
ES2004991A6 (es) Un procedimiento para preparar compuestos de quinazolinona.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee